SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,315.61 1,533.72
( 2.11%)

Global Indices

Nasdaq

51,633.03 -58.07
(-0.11%)

Dow Jones

7,740.63 -85.82
(-1.10%)

Hang Seng

64,657.00 -3,087.29
(-4.56%)

Nikkei 225

10,840.19 115.33
(1.08%)

Forex

USD-INR

95.22 -0.47
(-0.50%)

EUR-INR

106.51 -0.49
(-0.46%)

GBP-INR

126.04 -0.53
(-0.42%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9539136

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

152.72

101338.53

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.66

Back

Eiko Lifesciences consolidated net profit rises 23.81% in the March 2026 quarter

May 26,2026

Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	18.34	11.27	63	52.71	37.66	40
OPM %	12.32	11.62	-	14.10	7.33	-
PBDT	2.27	1.55	46	8.13	3.46	135
PBT	2.02	1.30	55	7.12	2.72	162
NP	1.30	1.05	24	4.50	2.11	113

74,315.61 1,533.72 ( 2.11%)

51,633.03 -58.07 (-0.11%)

7,740.63 -85.82 (-1.10%)

64,657.00 -3,087.29 (-4.56%)

10,840.19 115.33 (1.08%)

95.22 -0.47 (-0.50%)

106.51 -0.49 (-0.46%)

126.04 -0.53 (-0.42%)

0.60 0.00 (-0.36%)